Pre-clinical evaluation of gadobutrol: a new, neutral, extracellular contrast agent for magnetic resonance imaging.
暂无分享,去创建一个
H. Weinmann | W. Press | G. Schuhmann-Giampieri | T. Frenzel | H J Weinmann | G Schuhmann-Giampieri | W R Press | H Vogler | J Platzek | T Frenzel | B Radüchel | B. Radüchel | J. Platzek | H. Vogler
[1] L. Hedlund,et al. Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat. , 1991, Investigative radiology.
[2] J. Mulliken,et al. Major intravenous extravasation injuries. , 1979, American journal of surgery.
[3] J. Ehrhardt,et al. Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. , 1992, AJNR. American journal of neuroradiology.
[4] C. Arroyave. An In Vitro Assay for Radiographic Contrast Media Idiosyncrasy , 1980, Investigative radiology.
[5] T. Brady,et al. Albumin binding of paramagnetic hepatobiliary contrast agents: enhancement of outer sphere relaxivity. , 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[6] V. Runge,et al. High‐dose gadoteridol in MR imaging of intracranial neoplasms , 1992, Journal of magnetic resonance imaging : JMRI.
[7] W. Cacheris,et al. The relationship between thermodynamics and the toxicity of gadolinium complexes. , 1990, Magnetic resonance imaging.
[8] J W Belliveau,et al. Functional cerebral imaging by susceptibility‐contrast NMR , 1990, Magnetic resonance in medicine.
[9] T. Kozuka,et al. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. , 1990, Radiology.
[10] H. Niendorf,et al. Tolerance data of Gd-DTPA: a review. , 1991, European journal of radiology.
[11] Joseph P. Remington,et al. Remington's pharmaceutical sciences , 2016 .